Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

June 09, 2020; 94 (23) Special Editorial

Ethics in the time of COVID

What remains the same and what is different

Scott Y.H. Kim, Christine Grady
First published April 6, 2020, DOI: https://doi.org/10.1212/WNL.0000000000009520
Scott Y.H. Kim
From the Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Grady
From the Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Ethics in the time of COVID
What remains the same and what is different
Scott Y.H. Kim, Christine Grady
Neurology Jun 2020, 94 (23) 1007-1008; DOI: 10.1212/WNL.0000000000009520

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
4471

Share

  • Article
  • Info & Disclosures
Loading

“…you're wrong about things being different because they're not the same.”

—Cary Grant in The Awful Truth, 1937

The coronavirus disease of 2019 (COVID-19) pandemic raises difficult ethical questions for our health care system and its providers. Perhaps the most difficult is how to fairly distribute scarce resources, such as intensive care unit (ICU) beds and ventilators, as the answer will determine who lives and who dies. Compounding the difficulty, all of us are experiencing the dizzying newness of our socially distanced lives, and we sense that “things are different now.” How do our traditional ethical principles apply to these very novel circumstances?

This question is particularly relevant for patients with neurodegenerative and neuropsychiatric disorders and patients with neurologic disabilities who, to varying degrees, depend on others for their needs and/or to carry out their wishes. For instance, we know that COVID-19 is particularly lethal for the elderly with preexisting conditions. Elderly persons with dementias comprise a large number of such persons. They often reside in institutions, often inadequately staffed, within which spread of the virus is more difficult to control.

Furthermore, a crisis can magnify the social risk of stigma that such persons face in ordinary times. We know that the public's perception of the quality of life of those with dementias is worse than the stated experiences of patients themselves.1 Also, the cognitively impaired—even the very mildly impaired—will hardly be involved in conversations about crisis management. In the fog of crisis, their lives may seem more expendable, even if not so baldly framed. Indeed, in some resource allocation guidelines developed in the wake of earlier epidemics, people with cognitive impairments have been singled out for exclusions,2 and in other health care decisions of scarcity (e.g., organ transplants), those with neurodevelopmental disorders may face unjustified discrimination.3

It is therefore worth exploring what remains the same and what is different when it comes to ethics in a time of crisis for some of our society's most vulnerable patients.

What remains the same

Even in times of crisis, central ethical principles remain the same. Respect for persons and, in particular, respecting patients' wishes regarding their medical treatment remain paramount. Advance directives or other statements that convey patients' wishes remain crucial for end-of-life medical decision making for those unable to make their own decisions. Not inflicting patients with invasive treatments that they do not want must remain a high priority, as is the need to have compassionate, aggressive, and skilled palliative care available. Although the majority of older Americans now have advance directives, a significant minority do not. A time of pandemic may be a necessary time for persons still capable of expressing their wishes regarding end-of-life treatments to express their values and wishes to their loved ones and health care providers. This issue will become more and more relevant as the months pass.

For those whose wishes are not known, it is important to refrain from projecting our own fears and values onto patients' situations.4 Excluding persons merely based on their cognitive status or our assessment of their quality of life from the pool of candidates eligible for a scarce resource is unjustified discrimination. It is no more permissible to discriminate and stigmatize in a time of crisis than it is in normal times. Indeed, because of the sense that “things are different now,” there will be greater temptation to fall into such thinking.

What is different

In times of scarcity, considerations of justice come to the fore. Thus, public health priorities intrude on physician-patient relationships. In anticipation of shortages of critical resources, such as hospital/ICU beds and ventilators, state health authorities5 and task forces6 and bioethicists7,8 have developed many guidelines. There is as yet no universally accepted framework, but there are significant points of agreement.

All guidelines endorse the priority of short-term survival.5,–,8 Most but not all6 also add varying versions5,7,8 of long-term prognosis. These 2 rules capture the shared moral intuition that scarce resources should be used for “the greatest amount of good.” But there is less agreement on other rules that have intuitive moral appeal but are more difficult to apply, more context dependent, or just conceptually more complex. For instance, prioritizing health care workers, because they are crucial to fighting the pandemic, may make sense only if the crisis is expected to last long enough and the identified persons in fact would play key instrumental roles.7,8 The other common intuition is that the young ought to have priority over the old, but exactly how this should be implemented is controversial with a variety of proposals.6,8,9

Perhaps the most important point of agreement5,–,7,9,10 is that whatever framework is used must in some real and substantive sense engage and reflect the views of the public. There must be sufficient level of perceived legitimacy, a collective confidence that the rules and their application are fair and reflect the priorities of society.

This last point is important. Even if the rules themselves are perceived as fair, actual implementation may be susceptible to potentially discriminating practices because no rule interprets itself. Consider, for example, an allocation framework document that is reported as currently being adopted by hundreds of hospitals.10 It correctly advocates nondiscriminatory rules and explicitly advises against “categorical exclusions”; yet, in its system for incorporating long-term prognosis, the first example of “Major Comorbidities” is “moderate Alzheimer's disease or related dementia”, and the first example of “Severely Life Limiting Comorbidities” is “Severe Alzheimer's disease or related dementia.” As an empirical matter, the claims are true. But it is notable that the cognitively impaired are the first group to come to our mind even when neutral rules are being advocated. This is particularly relevant because whereas persons with malignancies, heart failure, lung disease, and renal disease will likely be able to advocate for themselves, persons with dementia are less able to do so.

Conclusion

We are living through truly novel times. Ethical principles remain the same, even if some become more significant than others as new contexts arise. For some of the most vulnerable persons in our society—those with brain disorders and neurologic disabilities who depend on others to maintain their welfare and dignity—the principle of respect remains paramount. This means following their prior stated wishes and, if able, encouraging them to plan for contingencies that could soon become realities. It also means that we need to be fair regardless of the type of impairment or perceived quality of life when we make tough decisions allocating limited resources.

Study funding

Supported in part by the Intramural Research Program, NIH.

Disclosure

The opinions expressed are the authors' and do not represent the views of the NIH, DHHS, or the US government. Go to Neurology.org/N for full disclosures.

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.

  • NPub.org/COVID19

  • © 2020 American Academy of Neurology

References

  1. 1.↵
    1. de Boer ME,
    2. Hertogh CM,
    3. Droes RM,
    4. Riphagen II,
    5. Jonker C,
    6. Eefsting JA
    . Suffering from dementia—the patient's perspective: a review of the literature. Int Psychogeriatr 2007;19:1021–1039.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Hensel W,
    2. Wolf LE
    . Playing god: the legality of plans denying scarce resources to people with disabilities in public health emergencies. Fla L Rev 2011;63:725; Georgia State University College of Law, Legal Studies Research Paper No. 2011-09. Available at SSRN: ssrn.com/abstract=1825565.
    OpenUrl
  3. 3.↵
    1. Richards CT,
    2. Crawley LM,
    3. Magnus D
    . Use of neurodevelopmental delay in pediatric solid organ transplant listing decisions: inconsistencies in standards across major pediatric transplant centers. Pediatr Transplant 2009;13:843–850.
    OpenUrlPubMed
  4. 4.↵
    1. Fink S
    . Strained by Katrina, a Hospital Faced Deadly Choices. In. The New York Times Magazine. August 30, 2009:1–18.
  5. 5.↵
    1. Daugherty-Biddison L,
    2. Gwon H,
    3. Regenberg A,
    4. Schoch-Spana M,
    5. Toner E
    . Maryland framework for the allocation of scarce life-sustaining medical resources in a catastrophic public health emergency. 2017. Available at: law.umaryland.edu/media/SOL/pdfs/Programs/Health-Law/MHECN/ASR%20Framework_Final.pdf. Accessed March 23, 2020.
  6. 6.↵
    New York State Task Force on Life and the Law, New York State Department of Health. Ventilator Allocation Guidelines. 2015. Available at: health.ny.gov/regulations/task_force/reports_publications/docs/ventilator_guidelines.pdf. Accessed March 24, 2020.
  7. 7.↵
    1. Emanuel EJ,
    2. Persad G,
    3. Upshur R, et al
    . Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med 2020. doi:10.1056/NEJMsb2005114.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. White DB,
    2. Katz MH,
    3. Luce JM,
    4. Lo B
    . Who should receive life support during a public health emergency? Using ethical principles to improve allocation decisions. Ann Intern Med 2009;150:132–138.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Persad G,
    2. Wertheimer A,
    3. Emanuel EJ
    . Principles for allocation of scarce medical interventions. Lancet 2009;373:423–431.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. White DB
    . Allocation of Scarce Critical Care Resources During a Public Health Emergency. 2020. Available at: bioethics.net/2020/03/allocation-of-scarce-critical-care-resources-during-a-public-health-emergency/. Accessed March 24, 2020.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • What remains the same
    • What is different
    • Conclusion
    • Study funding
    • Disclosure
    • Footnotes
    • References
  • Info & Disclosures
Advertisement

Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis

Dr. Robert Pitceathly and Dr. William Macken

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Special Article
    AAN position statement:
    The COVID-19 pandemic and the ethical duties of the neurologist
    Michael A. Rubin, Richard J. Bonnie, Leon Epstein et al.
    Neurology, May 15, 2020
  • Contemporary Issues
    Ethical decision-making for children with neuromuscular disorders in the COVID-19 crisis
    Naomi T. Laventhal, Robert J. Graham, Sonja A. Rasmussen et al.
    Neurology, June 01, 2020
  • Article
    Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis
    Guilhem Solé, Stéphane Mathis, Diane Friedman et al.
    Neurology, February 10, 2021
  • Views & Reviews
    Preserving stroke care during the COVID-19 pandemic
    Potential issues and solutions
    Enrique C. Leira, Andrew N. Russman, José Biller et al.
    Neurology, May 08, 2020
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise